Nisa Investment Advisors
RPRX icon

Nisa Investment Advisors’s Royalty Pharma RPRX Stock Holding History

Nisa Investment Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
24,400
+13,949
+133% +$726K ﹤0.01% 724
2026
Q1 		$501K Sell
10,451
-1,266
-11% -$55.4K ﹤0.01% 969
2025
Q4 		$453K Buy
11,717
+5,028
+75% +$192K ﹤0.01% 1032
2025
Q3 		$236K Sell
6,689
-21,957
-77% -$795K ﹤0.01% 1215
2025
Q2 		$1.03M Buy
+28,646
New +$949K ﹤0.01% 802
2024
Q2 		– Sell
-75,000
Closed -$2.28M – 2969
2024
Q1 		$2.28M Hold
75,000
– – 0.01% 660
2023
Q4 		$2.11M Buy
75,000
+68,900
+1,130% +$1.89M 0.01% 645
2023
Q3 		$166K Sell
6,100
-4,900
-45% -$146K ﹤0.01% 1355
2023
Q2 		$338K Buy
11,000
+6,700
+156% +$227K ﹤0.01% 1184
2023
Q1 		$155K Sell
4,300
-149,519
-97% -$5.54M ﹤0.01% 1364
2022
Q4 		$6.08M Buy
153,819
+143,660
+1,414% +$6M 0.05% 377
2022
Q3 		$415K Buy
+10,159
New +$434K ﹤0.01% 1091
2022
Q1 		– Sell
-9,244
Closed -$370K – 2388
2021
Q4 		$370K Sell
9,244
-1,783
-16% -$69.3K ﹤0.01% 1093
2021
Q3 		$399 Buy
+11,027
New +$429K ﹤0.01% 1183

Other funds holding RPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nisa Investment Advisors's RPRX Position: Q2 2026 in Review

Nisa Investment Advisors increased its Royalty Pharma (RPRX) stake by 133% in Q2 2026, buying an estimated $726K and bringing the position to 24,400 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Nisa Investment Advisors first reported a position in RPRX in Q3 2021 and has held it in 14 quarters since. The position peaked at $6.08M in Q4 2022. 319 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Nisa Investment Advisors held 24,400 shares of Royalty Pharma worth $1.37M as of Q2 2026.
  • Nisa Investment Advisors bought 13,949 Royalty Pharma shares in Q2 2026, an estimated $726K.
  • Royalty Pharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #724 holding.
  • Nisa Investment Advisors first reported a position in Royalty Pharma in Q3 2021 and has held it in 14 quarters since.
  • Nisa Investment Advisors's Royalty Pharma position peaked at $6.08M in Q4 2022.
  • 319 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.